Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome
β Scribed by Andrea Stonecipher; Redentor Galang; James Black
- Book ID
- 113635393
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 108 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0163-8343
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 67-year-old schizophrenic woman developed neuroleptic malignant syndrome (NMS). She had mild diabetes mellitus, which had been controlled with diet therapy only. Upon the onset of NMS, hyperglycemia of up to 490 mg/dl developed. The hyperglycemia persisted during the NMS episode despite insulin tr
## Abstract Neuroleptic malignantβlike syndrome (NMLS) is well described in the treatment of Parkinson's disease. The syndrome is characterized by fever, rigidity, autonomic instability, elevated creatine phosphokinase levels, and altered level of consciousness, which is usually precipitated by lev